Hydroxyurea and Growth in Young Children With Sickle Cell Disease

BACKGROUND: Growth impairment is a known complication of sickle cell disease. Effects of hydroxyurea (HU) on growth in very young children are not known. METHODS: Height, weight, BMI, and head circumference (HC) were compared with World Health Organization (WHO) standards in BABY HUG, a multicenter,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rana, Sohail, Houston, Patricia E., Wang, Winfred C., Iyer, Rathi V., Goldsmith, Jonathan, Casella, James F., Reed, Caroline K., Rogers, Zora R., Waclawiw, Myron A., Thompson, Bruce
Format: Artigo
Idioma:Inglês
Publicat: American Academy of Pediatrics 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144002/
https://ncbi.nlm.nih.gov/pubmed/25157002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2014-0917
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars